39893485|t|Delta-opioid receptor signaling alleviates neuropathology and cognitive impairment in the mouse model of Alzheimer's disease by regulating microglia homeostasis and inhibiting HMGB1 pathway.
39893485|a|BACKGROUND: Recent studies suggest that opioid receptor signaling may differentially affect Alzheimer's disease (AD) pathology and the relevant behavioral dysfunctions. However, the precise roles and mechanisms of opioid receptor subtypes in AD pathologies are still unclear with major controversies. METHODS: We compared the delta-opioid receptor (DOR)- and mu-opioid receptor (MOR)-mediated effects on AD-associated cognitive deficits, pathologies, neuroinflammations, cell death using transgenic APP/PS1 mouse model and BV2 cell line at behavioral, molecular, and cellular levels. Unpaired t-test and one/two way analysis for variance (ANOVA) were used to analyze statistical significance of the data. RESULTS: We show a distinct role of DOR and its major difference with MOR in AD injury in an APP/PS1 mouse model. DOR activation by UFP-512, but not MOR activation by DAMGO, attenuated cognitive impairment, reduced beta-amyloid (Abeta) production and aggregation, as well as protected the neurons from apoptosis in APP/PS1 mice. DOR and MOR also differentially modulated microglia in APP/PS1 mice and in vitro AD cell model with a DOR-mediated inhibition on the excessive activation of microglia and the release of pro-inflammatory cytokines in AD pathologies. Gene expression profiling further revealed that the alternations in DOR/MOR are closely associated with microglial homeostatic signatures and high mobility group protein B1 (HMGB1) in AD. DOR activation inhibited HMGB1 secretion and its translocation from nuclear to cytoplasm. Our in-vitro studies further confirmed that DOR overexpression mitigated microglial inflammatory response and rescued neurons from AD injury via HMGB1-NF-kappaB signaling pathway. CONCLUSIONS: These novel findings uncover previously unappreciated roles of DOR in neuroprotection against AD injury via modulating microglia-related inflammatory responses.
39893485	0	21	Delta-opioid receptor	Gene	18386
39893485	43	57	neuropathology	Disease	MESH:D009422
39893485	62	82	cognitive impairment	Disease	MESH:D003072
39893485	90	95	mouse	Species	10090
39893485	105	124	Alzheimer's disease	Disease	MESH:D000544
39893485	176	181	HMGB1	Gene	15289
39893485	283	302	Alzheimer's disease	Disease	MESH:D000544
39893485	304	306	AD	Disease	MESH:D000544
39893485	335	358	behavioral dysfunctions	Disease	MESH:D001523
39893485	433	435	AD	Disease	MESH:D000544
39893485	517	538	delta-opioid receptor	Gene	18386
39893485	540	543	DOR	Gene	18386
39893485	550	568	mu-opioid receptor	Gene	18390
39893485	570	573	MOR	Gene	18390
39893485	595	597	AD	Disease	MESH:D000544
39893485	609	627	cognitive deficits	Disease	MESH:D003072
39893485	642	660	neuroinflammations	Disease	MESH:D000090862
39893485	694	697	PS1	Gene	19164
39893485	698	703	mouse	Species	10090
39893485	714	717	BV2	CellLine	CVCL:0182
39893485	932	935	DOR	Gene	18386
39893485	966	969	MOR	Gene	18390
39893485	973	982	AD injury	Disease	MESH:D000544
39893485	993	996	PS1	Gene	19164
39893485	997	1002	mouse	Species	10090
39893485	1010	1013	DOR	Gene	18386
39893485	1028	1035	UFP-512	Chemical	MESH:C526539
39893485	1045	1048	MOR	Gene	18390
39893485	1081	1101	cognitive impairment	Disease	MESH:D003072
39893485	1125	1130	Abeta	Gene	11820
39893485	1215	1218	PS1	Gene	19164
39893485	1219	1223	mice	Species	10090
39893485	1225	1228	DOR	Gene	18386
39893485	1233	1236	MOR	Gene	18390
39893485	1284	1287	PS1	Gene	19164
39893485	1288	1292	mice	Species	10090
39893485	1306	1308	AD	Disease	MESH:D000544
39893485	1327	1330	DOR	Gene	18386
39893485	1415	1427	inflammatory	Disease	MESH:D007249
39893485	1441	1443	AD	Disease	MESH:D000544
39893485	1525	1528	DOR	Gene	18386
39893485	1529	1532	MOR	Gene	18390
39893485	1599	1629	high mobility group protein B1	Gene	15289
39893485	1631	1636	HMGB1	Gene	15289
39893485	1641	1643	AD	Disease	MESH:D000544
39893485	1645	1648	DOR	Gene	18386
39893485	1670	1675	HMGB1	Gene	15289
39893485	1779	1782	DOR	Gene	18386
39893485	1819	1831	inflammatory	Disease	MESH:D007249
39893485	1866	1875	AD injury	Disease	MESH:D000544
39893485	1880	1885	HMGB1	Gene	15289
39893485	1886	1895	NF-kappaB	Gene	18033
39893485	1991	1994	DOR	Gene	18386
39893485	2022	2031	AD injury	Disease	MESH:D000544
39893485	2065	2077	inflammatory	Disease	MESH:D007249
39893485	Association	MESH:D000544	15289
39893485	Negative_Correlation	MESH:C526539	11820
39893485	Association	MESH:D000544	18033
39893485	Negative_Correlation	MESH:D009422	18386
39893485	Negative_Correlation	MESH:D007249	18386
39893485	Negative_Correlation	11820	18386
39893485	Positive_Correlation	MESH:C526539	18386
39893485	Negative_Correlation	MESH:D003072	18386
39893485	Negative_Correlation	MESH:C526539	MESH:D003072
39893485	Association	15289	18390
39893485	Association	18033	18386
39893485	Negative_Correlation	15289	18386
39893485	Association	15289	18033
39893485	Association	MESH:D000544	18386
39893485	Association	MESH:D000544	18390

